Parkinsonismo de tipo secundario
El tratamiento de las afecciones que pueden causar el parkinsonismo secundario puede disminuir el riesgo de que éste se presente. El uso de medicamentos debe hacerse únicamente bajo la supervisión del médico y se debe vigilar a las personas con afecciones que requieran el uso prolongado de antipsicóticos, como la esquizofrenia, para evitar el desarrollo de parkinsonismo secundario irreversible. Los medicamentos antipsicóticos más nuevos tienen menos probabilidad de causar parkinsonismo secundario.
U.S. Food and Drug Administration. FDA Approves Neupro Patch for Treatment of Early Parkinson's Disease . Rockville, MD: National Press Office; May 9, 2007. Release P07-84.
Goetz, CG. Textbook of Clinical Neurology . 2nd ed. St. Louis, Mo: WB Saunders; 2003: 713-720.
Noble J. Textbook of Primary Care Medicine . 3rd ed. St. Louis, Mo: Mosby; 2001:1612-1618.
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |